BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21918361)

  • 1. [Cetuximab-associated skin ulceration in patient with metastatic colorectal cancer: a case report].
    Tsuboi K; Kawase Y; Okochi O; Hattori M; Takami Y; Takeda S; Mizuno A; Sato Y; Uno Y; Hayashi T; Sasada Y; Takamura S; Kozaki K
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1549-52. PubMed ID: 21918361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
    Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
    Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOLFOX plus cetuximab for a patient with metastatic colorectal cancer with icterus due to multiple liver metastases.
    Mizota A; Shitara K; Kondo C; Nomura M; Yokota T; Takahari D; Ura T; Muro K
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1205-8. PubMed ID: 21772113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Elderly patient with recurrent rectal cancer successfully responded to modified FOLFOX6 chemotherapy with bevacizumab--a case report].
    Tsuboi K; Kawase Y; Kato N; Okochi O; Matsushita H; Hattori M; Takami Y; Takeda S; Mizuno A; Adachi E; Sato Y; Kuroiwa M
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):1163-5. PubMed ID: 20567129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of recurrent rectal cancer with paraaortic lymph node metastasis treated by FOLFIRI therapy leading to complete response].
    Yatsuoka T; Nishimura Y; Sakamoto H; Tanaka Y; Yamaguchi K
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2057-9. PubMed ID: 22202283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case report of recurrent lung metastasis after surgery for rectal cancer for which lung radiofrequency ablation therapy and long-term administration of FOLFIRI were effective].
    Suzuki N; Suzuki S; Tominaga K; Hoshino M; Naruse H; Fukushima M; Murakami M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2267-9. PubMed ID: 23268045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [FOLFIRI with bevacizumab chemotherapy for a patient with recurrence of rectal cancer under haemodialysis for chronic renal failure].
    Hoshino H; Ishii Y; Hasegawa H; Endo T; Ochiai H; Hoshino Y; Matsunaga A; Shigeta K; Seo Y; Hoshino G; Kitagawa Y
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):983-6. PubMed ID: 22705698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent disease four years after surgery and adjuvant chemotherapy.
    Pozzo C; Barone C
    Cancer Treat Rev; 2008; 34 Suppl 2():S8-11. PubMed ID: 19101406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cetuximab/targeted chemotherapy in an HIV-positive patient with metastatic colorectal cancer in the HAART era: a case report.
    Berretta M; Martellotta F; Simonelli C; Di Benedetto F; De Ruvo N; Drigo A; Bearz A; Spina M; Zanet E; Berretta S; Tirelli U
    J Chemother; 2007 Jun; 19(3):343-6. PubMed ID: 17594933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful long-term management of a patient with late-stage metastatic colorectal cancer treated with panitumumab.
    Seront E; Marot L; Coche E; Gala JL; Sempoux C; Humblet Y
    Cancer Treat Rev; 2010 Feb; 36 Suppl 1():S11-4. PubMed ID: 20189054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effective cetuximab monotherapy for a case of recurrence rectal cancer after multiple previous chemotherapy treatment (FOLFOX, FOLFIRI)].
    Tomita M; Kuboi K; Kameyama N; Mitsuhashi H; Matsumoto N; Hasegawa Y; Sekimoto Y
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):121-4. PubMed ID: 21368472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of multiple lung and liver metastases from colon cancer treated with clinical benefit by hepatic arterial infusion chemotherapy plus cetuximab mono-therapy after standard chemotherapy failure].
    Osawa G; Yoshimatsu K; Yokomizo H; Otani T; Yano Y; Itagaki H; Matsumoto A; Fujimoto T; Umehara A; Ogawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2526-8. PubMed ID: 21224628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bevacizumab in combination with mFOLFOX6 or FOLFIRI for previously treated metastatic colorectal cancer].
    Koyama M; Murata A; Kimura Y; Sakamoto Y; Morohashi H; Kimura N; Gasa F; Sato J; Terui K; Awatsu A; Hakamada K
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):1069-73. PubMed ID: 20567110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and economic evaluation of first-line therapy with FOLFIRI or modified FOLFOX6 for metastatic colorectal cancer.
    Ajima H; Ogata H; Fujita K; Miwa K; Sunakawa Y; Mizuno K; Ishida H; Yamashita K; Nakayama H; Kawara K; Takahashi H; Sasaki Y
    Jpn J Clin Oncol; 2010 Jul; 40(7):634-8. PubMed ID: 20587616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Huge unresectable multiple hepatic metastases of rectum cancer responding to combined therapy with FOLFIRI +bevacizumab - a case report].
    Tagami Y; Ogata S; Katakawa M; Bando Y
    Gan To Kagaku Ryoho; 2012 Feb; 39(2):317-9. PubMed ID: 22333652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase IV study of bevacizumab in combination with infusional fluorouracil, leucovorin and irinotecan (FOLFIRI) in first-line metastatic colorectal cancer.
    Sobrero A; Ackland S; Clarke S; Perez-Carrión R; Chiara S; Gapski J; Mainwaring P; Langer B; Young S;
    Oncology; 2009; 77(2):113-9. PubMed ID: 19628950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of liver metastases from rectal cancer showed a complete response by FOLFIRI and bevacizumab chemotherapy].
    Kuwada A; Nakamitsu A; Imamura Y; Kouyama M; Uekami S; Touge K; Taogoshi H; Fukuda Y; Daimaru H
    Gan To Kagaku Ryoho; 2010 Dec; 37(13):2937-40. PubMed ID: 21160275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of drug-induced lung injury associated with chemotherapy (FOLFOX6, FOLFIRI, Bevacizumab) for an advanced colon cancer].
    Komaki C; Hanatate F; Kobayashi K
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):113-6. PubMed ID: 21368470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.